Status:
COMPLETED
CCRO044: Quality of Life Assessments Associated With a Physician Communication Intervention for Prostate Cancer Patients
Lead Sponsor:
University of California, Davis
Conditions:
Prostate Adenocarcinoma
Eligibility:
MALE
18+ years
Brief Summary
A generic cancer health-related quality of life measure will be used to assess the impact of the patient-specific radiation therapy plan review using the European Organisation for Research and Treatme...
Detailed Description
The primary purpose of this pilot study is to assess the feasibility of administrating a battery of HRQL measures after the planned intervention is administered. Because distributional information on ...
Eligibility Criteria
Inclusion
- Diagnosis of prostate adenocarcinoma over the age of 18 years
- Low, intermediate or high risk as defined by D'Amico risk groups treated with dose escalated conventional fractionated radiation therapy
- Patient deemed clinically appropriate for definitive, adjuvant or salvage radiation.
- Patient most provide study specific informed consent prior to study entry.
- Androgen deprivation allowed
- Pelvic lymph radiation therapy allowed for high risk disease
Exclusion
- Metastatic prostate cancer
- Positive pelvic nodes
- Patients treated with radiation for palliative intent
- Prior radiation therapy to the pelvis
Key Trial Info
Start Date :
July 17 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 4 2020
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT03780023
Start Date
July 17 2017
End Date
May 4 2020
Last Update
October 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Davis Health
Sacramento, California, United States, 95817